Millennium Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Millennium Management’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-38,093	Closed	-$149K	–	6863
2023 Q3	$149K	Buy	+38,093	New	+$260K	﹤0.01%	5222
2023 Q2	–	Sell	-2,921	Closed	-$11K	–	6987
2023 Q1	$11K	Sell	2,921 -1,771	-38%	-$27.3K	﹤0.01%	6019
2022 Q4	$151K	Sell	4,692 -4,541	-49%	-$180K	﹤0.01%	5437
2022 Q3	$386K	Sell	9,233 -424	-4%	-$19.4K	﹤0.01%	5180
2022 Q2	$408K	Buy	9,657 +7,481	+344%	+$347K	﹤0.01%	5116
2022 Q1	$148K	Sell	2,176 -3,247	-60%	-$270K	﹤0.01%	5976
2021 Q4	$658K	Buy	5,423 +4,473	+471%	+$755K	﹤0.01%	4802
2021 Q3	$134K	Sell	950 -1,577	-62%	-$312K	﹤0.01%	6302
2021 Q2	$694K	Sell	2,527 -3,713	-60%	-$937K	﹤0.01%	5001
2021 Q1	$1.33M	Buy	6,240 +4,245	+213%	+$1.17M	﹤0.01%	3913
2020 Q4	$482K	Sell	1,995 -5,612	-74%	-$694K	﹤0.01%	4227
2020 Q3	$802K	Buy	7,607 +6,321	+492%	+$576K	﹤0.01%	3292
2020 Q2	$126K	Buy	1,286 +715	+125%	+$62.6K	﹤0.01%	3946
2020 Q1	$43K	Buy	+571	New	+$54.4K	﹤0.01%	3679

Other funds holding EVLO

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Millennium Management's EVLO Position: Q4 2023 in Review

Millennium Management sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 38,093 shares — an estimated $149K sold.

Millennium Management first reported a position in EVLO in Q1 2020 and held it in 14 quarters. The position peaked at $1.33M in Q1 2021. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

Millennium Management reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Millennium Management sold 38,093 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $149K.
Millennium Management first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
Millennium Management's Evelo Biosciences, Inc. Common Stock position peaked at $1.33M in Q1 2021.
2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.